Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-8236 Allergen Challenge Study in Asthma
NCT04150341Phase 2Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Nov 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TD-8236 in asthma, sponsored by Theravance Biopharma, Inc.. Started Nov 2019; status: completed.
02
Drugs
TD-8236
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04150341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150341.